1. Home
  2. ANL vs INUV Comparison

ANL vs INUV Comparison

Compare ANL & INUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANL
  • INUV
  • Stock Information
  • Founded
  • ANL 2004
  • INUV N/A
  • Country
  • ANL Cayman Islands
  • INUV United States
  • Employees
  • ANL N/A
  • INUV N/A
  • Industry
  • ANL
  • INUV Advertising
  • Sector
  • ANL
  • INUV Consumer Discretionary
  • Exchange
  • ANL Nasdaq
  • INUV Nasdaq
  • Market Cap
  • ANL 79.0M
  • INUV 68.8M
  • IPO Year
  • ANL 2023
  • INUV N/A
  • Fundamental
  • Price
  • ANL $2.25
  • INUV $0.43
  • Analyst Decision
  • ANL Strong Buy
  • INUV Strong Buy
  • Analyst Count
  • ANL 2
  • INUV 1
  • Target Price
  • ANL $9.00
  • INUV $1.00
  • AVG Volume (30 Days)
  • ANL 5.8K
  • INUV 780.1K
  • Earning Date
  • ANL 03-04-2025
  • INUV 02-27-2025
  • Dividend Yield
  • ANL N/A
  • INUV N/A
  • EPS Growth
  • ANL N/A
  • INUV N/A
  • EPS
  • ANL N/A
  • INUV N/A
  • Revenue
  • ANL $5,000,000.00
  • INUV $78,446,030.00
  • Revenue This Year
  • ANL N/A
  • INUV $14.39
  • Revenue Next Year
  • ANL N/A
  • INUV $27.95
  • P/E Ratio
  • ANL N/A
  • INUV N/A
  • Revenue Growth
  • ANL N/A
  • INUV 11.52
  • 52 Week Low
  • ANL $1.85
  • INUV $0.19
  • 52 Week High
  • ANL $17.48
  • INUV $0.79
  • Technical
  • Relative Strength Index (RSI)
  • ANL 57.33
  • INUV 43.39
  • Support Level
  • ANL $2.00
  • INUV $0.42
  • Resistance Level
  • ANL $2.15
  • INUV $0.50
  • Average True Range (ATR)
  • ANL 0.11
  • INUV 0.04
  • MACD
  • ANL 0.03
  • INUV -0.01
  • Stochastic Oscillator
  • ANL 59.52
  • INUV 25.62

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

About INUV Inuvo Inc.

Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications, and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

Share on Social Networks: